"This agreement represents a major milestone for Amarantus, as we can now prepare LymPro for launch with a top-tier commercial development organization with the required CLIA capabilities as the backbone for launch in the United States and abroad,"
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links